Catch up on the top radiology content of the past week.
|Articles|November 23, 1994
Sopha's DST-XL targets body imaging
Holding the spotlight in SophaMedical's booth will be Sophycamera DST-XL, a new version of theFrench nuclear medicine vendor's variable-angle dual-head technology.The gamma camera was unveiled at the Society of Nuclear Medicinemeeting in Orlando (SCAN
Advertisement
Holding the spotlight in SophaMedical's booth will be Sophycamera DST-XL, a new version of theFrench nuclear medicine vendor's variable-angle dual-head technology.The gamma camera was unveiled at the Society of Nuclear Medicinemeeting in Orlando (SCAN 6/1/94).
Sophycamera DST-XL has jumbo detector heads, each with a field-of-viewof 21.2 x 15.75 inches, making the camera more appropriate forwhole-body studies compared to the Sophycamera DST. The DST willremain in Sopha's lineup and will be marketed more to the cardiacniche, according to president Colin McNaught.
As a work-in-progress, Sopha will display for the first timeits work in developing a simultaneous transmission-emission attenuationcorrection technique for its products. Picker International releasedan artifact correction technique this summer, and other vendorsare also developing similar products (SCAN 6/1/94).
In addition, Sopha will introduce MedNet, a PC-based solutionthat provides a DICOM 3.0 gateway for Sopha customers to communicatewith other imaging devices. Sopha will also offer MedNet in asoftware-only configuration, according to McNaught.
Advertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
3
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
4
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
5